Gilead signs sales deal with Glaxo for Viread

Gilead Sciences Inc. and GlaxoSmithKline said Tuesday they signed a deal to sell Viread as a hepatitis B treatment in Asia. (AP, 11/24/09)

Millipore to own all of India venture

BILLERICA - Millipore Corp. , a provider of equipment and services to the life sciences industry, said yesterday that it will buy the remaining stake in its joint venture in India, Millipore India Pvt. Ltd. (Boston Globe, 11/23/09)

Biotech bills give drugmakers too many years of exclusivity

The Biotech industry is vital to Massachusetts and deserves robust protection of its intellectual property. But the long-awaited bills emerging from the House and Senate give too many years of exclusivity to the original makers of biotech drugs -- 12 instead of five for regular drugs -- and serve to drive up healthcare costs. A compromise is in order. (Boston Globe, 11/23/09)

Abiomed puts focus on cardiac pumps, not artificial hearts

DANVERS - The cardiac device company Abiomed Inc. captured attention in June when its AbioCor self-contained artificial heart was implanted in a patient for the first time outside of a clinical trial. (Boston Globe, 11/22/09)

Ironwood Pharmaceuticals plans IPO

Ironwood Pharmaceuticals, a Cambridge biotechnology company developing a treatment for irritable bowel syndrome, yesterday filed plans to go public. (Boston Globe, 11/20/09)